- Oncogenic DDX46 promotes pancreatic cancer development and gemcitabin…
Number of the records: 1  

Oncogenic DDX46 promotes pancreatic cancer development and gemcitabine resistance by facilitating the JMJD6/CDK4 signaling pathway

  1. Oncogenic DDX46 promotes pancreatic cancer development and gemcitabine resistance by facilitating the JMJD6/CDK4 signaling pathway / Guang Yang ... [et al.]. Neoplasma Vol. 71, no. 3 (2024), s. 231-242
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all